SMGT-GLP-1, also known as semaglutide, is definitely a great treatment
Its common adverse reactions are similar to other GLP-1 drugs, primarily consisting of gastrointestinal issues (nausea, diarrhea, vomiting, etc.), which are mostly mild to moderate and typically decrease over time
GIP receptors are found on alpha-cells and also on delta-cells and polypeptide gamma-cells of the endocrine pancreas
Semaglutide works by mimicking the action of endogenous GLP-1 , enhancing glucose-dependent insulin secretion, suppressing glucagon release, and slowing gastric emptying
Recognizing warning signs ensures timely intervention and prevents serious complications
Yokoyama H, Tsuruta O, Akao N, Fujii S